Venture Capital

A new once-daily pill for hypoparathyroidism begins human testing, promising to replace burdensome injections and transform patient care. Is this the future?

Amid shrinking newsrooms and the rise of AI, a 55-year-old RI agency’s Gold Merit Award proves strategic specialization is key to earning credibility.

A Canadian drone maker gains top military approval in Ukraine, leveraging its unique 'ITAR-flexible' status to meet surging global defense demand.

After securing over $600M in verdicts against Samsung and Twitter/X, a Texas law firm sweeps top IP awards, cementing its elite status.

Stryten's new M-Series Li610 battery promises 24/7 uptime for forklifts, part of a smart ecosystem aimed at redefining warehouse efficiency.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

SwitchBot’s cult-classic button-pusher gets a sustainable upgrade. The new rechargeable model promises less waste and more convenience for every home.

Fresh off a massively oversubscribed IPO, Chinese robotics firm Huayan debuts at Hannover Messe, challenging industry giants with advanced AI and automation.

Backed by Maria Sharapova, new startup Amulet launches a science-first supplement aiming to optimize women's performance throughout their entire cycle.

Over 2000 leaders will gather for the FNMPC conference, focusing on Indigenous equity ownership in major projects to build generational wealth.

Former Hartbeat CEO Thai Randolph acquires As/Is and Goodful from BuzzFeed, launching a new venture to build legacy brands with creators as equity partners.

With a $1M+ direct-to-player presale and a $100K tournament prize pool, Azuki's 'Gates Awakened' makes a bold entrance into the competitive card game scene.

Acclaimed director Hirokazu Kore-eda receives a prestigious award for his artistic vision and industry advocacy, highlighting a pivotal moment for cinema.

Fresh from bankruptcy, WeWork launches 'WeWork Go' pods for airports and busy hubs. Is this the key to its rebound and the future of work-on-the-go?

With promising Phase 2 data for its novel peptide therapies, Sapience Therapeutics is engaging investors, signaling a critical push for future growth.

With a fresh $12M in funding, Canadian fintech Common Wealth is using AI and a modern platform to bring retirement plans to underserved small businesses.

A new partnership introduces PBSerum®, a biologically inspired enzyme treatment, aiming to redefine skin quality in the multi-billion dollar aesthetics market.

L2L's new Execution AI, built on AWS, promises to move factories from reactive chaos to proactive intelligence, addressing a decade of stagnant output.

A top UK defense data expert moves to the private sector, highlighting the critical role of AI in the growing shadow war of economic espionage.

A new robotic platform with fingertip controls and remote surgery capabilities aims to overcome barriers to life-saving mechanical thrombectomy for stroke.